Arrowhead Pharmaceuticals (ARWR) Earnings Date, Estimates & Call Transcripts $15.71 +0.37 (+2.41%) Closing price 05/16/2025 04:00 PM EasternExtended Trading$15.49 -0.22 (-1.40%) As of 05/16/2025 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Arrowhead Pharmaceuticals Earnings Summary Arrowhead Pharmaceuticals issued Q2 2025 earnings on May 12, 2025, reporting an EPS of $2.75, which topped analysts' consensus estimates of -$0.06 by $2.81. Quarterly revenue was reported to be $542.71 million, above analyst estimates of $116.27 million. With a trailing EPS of -$1.40, Arrowhead Pharmaceuticals' earnings are expected to decrease next year, from ($2.42) to ($3.16) per share. Latest Q2 Earnings DateMay. 12EstimatedConsensus EPS (May. 12) -$0.06 Actual EPS (May. 12) $2.75 Beat By $2.81 Actual Revenue (May. 12) $542.71MQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)Powered by Get Arrowhead Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arrowhead Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataARWR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ARWR Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Arrowhead Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$1.07-$1.07-$1.07Q2 20254-$1.01$2.66$0.18Q3 20254-$1.24-$0.29-$0.94Q4 20254-$1.00$1.05$0.33 Arrowhead Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/12/2025Q2 2025-$0.06$2.75+$2.81$2.75$116.27M$542.71M2/10/2025Q1 2025-$0.42-$1.39 -$0.97-$1.39$19.05M-8/8/2024Q3 2024-$0.58-$1.38 -$0.80-$1.38$52.87M-5/9/2024Q2 2024-$0.06-$1.02 -$0.96-$1.02$41.97M-2/6/2024Q1 2024-$0.78-$1.24 -$0.46-$1.24$35.60M$3.55M11/29/2023Q4 2023-$0.70-$1.03 -$0.33-$1.03$38.87M$16.10M8/7/2023Q3 2023-$0.58-$0.96 -$0.38-$0.96$45.42M$15.83M Arrowhead Pharmaceuticals Earnings - Frequently Asked Questions When did Arrowhead Pharmaceuticals announce their last quarterly earnings? Arrowhead Pharmaceuticals (NASDAQ:ARWR) last announced its quarterly earning data on Monday, May 12, 2025. Learn more on ARWR's earnings history. Did Arrowhead Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported $2.75 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.06) by $2.81. Learn more on analysts' earnings estimate vs. ARWR's actual earnings. How can I listen to Arrowhead Pharmaceuticals's earnings conference call? The conference call for Arrowhead Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Arrowhead Pharmaceuticals's conference call transcript? The conference call transcript for Arrowhead Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Arrowhead Pharmaceuticals generate each year? Arrowhead Pharmaceuticals (NASDAQ:ARWR) has a recorded annual revenue of $545.21 million. How much profit does Arrowhead Pharmaceuticals generate each year? Arrowhead Pharmaceuticals (NASDAQ:ARWR) has a recorded net income of -$599.49 million. ARWR has generated -$1.40 earnings per share over the last four quarters. What is Arrowhead Pharmaceuticals's EPS forecast for next year? Arrowhead Pharmaceuticals's earnings are expected to decrease from ($2.42) per share to ($3.16) per share in the next year. More Earnings Resources from MarketBeat Related Companies BBIO Earnings Results BPMC Earnings Results ELAN Earnings Results LEGN Earnings Results TGTX Earnings Results VRNA Earnings Results AXSM Earnings Results LNTH Earnings Results GRFS Earnings Results NUVL Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum Holds This page (NASDAQ:ARWR) was last updated on 5/18/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowMusk has launched a bold new AI initiative—and while you can’t invest in it directly, one overlooked stock cou...Behind the Markets | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arrowhead Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arrowhead Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARWR Stock Free ARWR Stock Alerts